NDC00015-0503-01: CYCLOPHOSPHAMIDE TABLETS.
The CYCLOPHOSPHAMIDE TABLETS is a the manufacturer industrial component. Key specifications include special_features: ANHYDROUS CYCLOSPHAMIDE ACTIVE INGREDIENT, primary_container_type: BOTTLE, protective_storage_feature: ANTINEOPLASTIC DRUG, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 100.000 TABLETS, active_medicament_medicinal_strength: 50.000 MILLIGRAMS CYCLOPHOSPHAMIDE ACTIVE INGREDIENT. This part is cataloged in the U.S.
Government catalog under NSN 6505-00-733-5246, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | ANHYDROUS CYCLOSPHAMIDE ACTIVE INGREDIENT |
| primary_container_type | BOTTLE |
| protective_storage_feature | ANTINEOPLASTIC DRUG |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 100.000 TABLETS |
| active_medicament_medicinal_strength | 50.000 MILLIGRAMS CYCLOPHOSPHAMIDE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | CYCLOPHOSPHAMIDE TABLETS USP 50 MG 100S |
| NSN | 6505-00-733-5246 |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | ANHYDROUS CYCLOSPHAMIDE ACTIVE INGREDIENT |
| PROTECTIVE STORAGE FEATURE | ANTINEOPLASTIC DRUG |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CYCLOPHOSPHAMIDE TABLETS USP 50 MG 100S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 50.000 MILLIGRAMS CYCLOPHOSPHAMIDE ACTIVE INGREDIENT |